134 related articles for article (PubMed ID: 33189835)
21. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.
Qi W; Morales C; Cooke LS; Johnson B; Somer B; Mahadevan D
Oncotarget; 2015 Dec; 6(39):41976-87. PubMed ID: 26506516
[TBL] [Abstract][Full Text] [Related]
22. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
23. A Novel lnc-RNA, Named lnc-ORA, Is Identified by RNA-Seq Analysis, and Its Knockdown Inhibits Adipogenesis by Regulating the PI3K/AKT/mTOR Signaling Pathway.
Cai R; Tang G; Zhang Q; Yong W; Zhang W; Xiao J; Wei C; He C; Yang G; Pang W
Cells; 2019 May; 8(5):. PubMed ID: 31109074
[TBL] [Abstract][Full Text] [Related]
24. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
25. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy.
Basualto-Alarcón C; Jorquera G; Altamirano F; Jaimovich E; Estrada M
Med Sci Sports Exerc; 2013 Sep; 45(9):1712-20. PubMed ID: 23470307
[TBL] [Abstract][Full Text] [Related]
26. Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.
Thomas C; Lamoureux F; Crafter C; Davies BR; Beraldi E; Fazli L; Kim S; Thaper D; Gleave ME; Zoubeidi A
Mol Cancer Ther; 2013 Nov; 12(11):2342-55. PubMed ID: 23966621
[TBL] [Abstract][Full Text] [Related]
27. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers.
Lin HK; Hu YC; Yang L; Altuwaijri S; Chen YT; Kang HY; Chang C
J Biol Chem; 2003 Dec; 278(51):50902-7. PubMed ID: 14555644
[TBL] [Abstract][Full Text] [Related]
28. Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Nachiappa Ganesh R
Aging Male; 2020 Dec; 23(5):440-446. PubMed ID: 30295140
[TBL] [Abstract][Full Text] [Related]
29. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.
Wang Y; Kreisberg JI; Ghosh PM
Curr Cancer Drug Targets; 2007 Sep; 7(6):591-604. PubMed ID: 17896924
[TBL] [Abstract][Full Text] [Related]
30. Testosterone Promotes the Proliferation of Chicken Embryonic Myoblasts Via Androgen Receptor Mediated PI3K/Akt Signaling Pathway.
Li D; Wang Q; Shi K; Lu Y; Yu D; Shi X; Du W; Yu M
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050491
[TBL] [Abstract][Full Text] [Related]
31. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
[TBL] [Abstract][Full Text] [Related]
33. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts.
Kang HY; Cho CL; Huang KL; Wang JC; Hu YC; Lin HK; Chang C; Huang KE
J Bone Miner Res; 2004 Jul; 19(7):1181-90. PubMed ID: 15177002
[TBL] [Abstract][Full Text] [Related]
34. Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway.
Yang M; Xu Z; Zhuang Z
Tissue Cell; 2020 Jun; 64():101343. PubMed ID: 32473708
[TBL] [Abstract][Full Text] [Related]
35. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
36. Human sperm express a functional androgen receptor: effects on PI3K/AKT pathway.
Aquila S; Middea E; Catalano S; Marsico S; Lanzino M; Casaburi I; Barone I; Bruno R; Zupo S; Andò S
Hum Reprod; 2007 Oct; 22(10):2594-605. PubMed ID: 17656415
[TBL] [Abstract][Full Text] [Related]
37. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
38. Increase in prostate stem cell antigen expression in prostatic hyperplasia induced by testosterone and 17β-estradiol in C57BL mice.
Fujimoto N; Kanno J
J Steroid Biochem Mol Biol; 2016 Apr; 158():56-62. PubMed ID: 26815912
[TBL] [Abstract][Full Text] [Related]
39. Electro-acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway.
Zhang H; Qin F; Liu A; Sun Q; Wang Q; Xie S; Lu S; Zhang D; Lu Z
Life Sci; 2019 Jan; 217():169-175. PubMed ID: 30521869
[TBL] [Abstract][Full Text] [Related]
40. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
